Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Ford

Showing results (1221-1230 of 1,228) with videos related to

Pageof 123
Sort By:
You have reached the last page of results.This site can display upto 1,228 results.
Stroke|December 15, 2020
Early Neurological Change After Ischemic Stroke Is Associated With 90-Day OutcomeLaura Heitsch, Laura Ibanez, Caty Carrera, et al.
BMJ Open|May 17, 2023
ADAMS project: a genetic Association study in individuals from Diverse Ancestral backgrounds with Multiple Sclerosis based in the UKBenjamin M Jacobs, Luisa Schalk, Angie Dunne, et al.
Lancet (London, England)|October 4, 2025
Effect of repurposed simvastatin on disability progression in secondary progressive multiple sclerosis (MS-STAT2): a phase 3, randomised, double-blind, placebo-controlled trialJeremy Chataway, Thomas Williams, James Blackstone, et al.
BMJ Open|September 16, 2024
Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UKJames Blackstone, Thomas Williams, Jennifer M Nicholas, et al.
Health Technology Assessment (Winchester, England)|June 29, 2026
Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis: a synopsis of MS-STAT2, a multicentre, randomised controlled, double-blind, phase 3 clinical trialThomas Williams, James Blackstone, Nevin John, et al.
Brain : a Journal of Neurology|February 25, 2022
Multi-ancestry GWAS reveals excitotoxicity associated with outcome after ischaemic strokeLaura Ibanez, Laura Heitsch, Caty Carrera, et al.
Neurology|March 6, 2026
Genetic Determinants of Multiple Sclerosis Susceptibility in People From Diverse Ancestral BackgroundsBenjamin Meir Jacobs, Luisa Schalk, Emily Tregaskis-Daniels, et al.
Medrxiv : the Preprint Server for Health Sciences|November 11, 2020
Multi-ancestry genetic study in 5,876 patients identifies an association between excitotoxic genes and early outcomes after acute ischemic strokeLaura Ibanez, Laura Heitsch, Caty Carrera, et al.
Pageof 123

Showing results (1221-1230 of 1,228) with videos related to

Sort By:
Pageof 123
You have reached the last page of results.This site can display upto 1,228 results.
Stroke|December 15, 2020
Early Neurological Change After Ischemic Stroke Is Associated With 90-Day OutcomeLaura Heitsch, Laura Ibanez, Caty Carrera, et al.
BMJ Open|May 17, 2023
ADAMS project: a genetic Association study in individuals from Diverse Ancestral backgrounds with Multiple Sclerosis based in the UKBenjamin M Jacobs, Luisa Schalk, Angie Dunne, et al.
Lancet (London, England)|October 4, 2025
Effect of repurposed simvastatin on disability progression in secondary progressive multiple sclerosis (MS-STAT2): a phase 3, randomised, double-blind, placebo-controlled trialJeremy Chataway, Thomas Williams, James Blackstone, et al.
BMJ Open|September 16, 2024
Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UKJames Blackstone, Thomas Williams, Jennifer M Nicholas, et al.
Health Technology Assessment (Winchester, England)|June 29, 2026
Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis: a synopsis of MS-STAT2, a multicentre, randomised controlled, double-blind, phase 3 clinical trialThomas Williams, James Blackstone, Nevin John, et al.
Brain : a Journal of Neurology|February 25, 2022
Multi-ancestry GWAS reveals excitotoxicity associated with outcome after ischaemic strokeLaura Ibanez, Laura Heitsch, Caty Carrera, et al.
Neurology|March 6, 2026
Genetic Determinants of Multiple Sclerosis Susceptibility in People From Diverse Ancestral BackgroundsBenjamin Meir Jacobs, Luisa Schalk, Emily Tregaskis-Daniels, et al.
Medrxiv : the Preprint Server for Health Sciences|November 11, 2020
Multi-ancestry genetic study in 5,876 patients identifies an association between excitotoxic genes and early outcomes after acute ischemic strokeLaura Ibanez, Laura Heitsch, Caty Carrera, et al.
Pageof 123